Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial

Mirza, Mansoor R.; Benigno, B.; Dørum, A.; Mahner, S.; Bessette, P.; Barceló, I. Bover; Berton-Rigaud, D.; Ledermann, J. A.; Rimel, B. J.; Herrstedt, J.; Lau, S.; du Bois, A.; Herráez, A. Casado; Kalbacher, E.; Buscema, J.; Lorusso, D.; Vergote, I.; Levy, T.; Wang, P.; de Jong, F. A.; Gupta, D.; Matulonis, U. A.